Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

American Home Products CEO-Designate Essner Will Succeed Stafford May 1

Executive Summary

American Home Products is capping a year of corporate clean-up with the formal announcement that President Robert Essner will succeed Jack Stafford as CEO May 1.

You may also be interested in...



Poussot Tapped As Wyeth CEO – Inherits Full Pipeline, Takeover Concerns

With the appointment of 20-year veteran Bernard Poussot as CEO, Wyeth is following a traditional approach to chief exec succession -avoiding drama by selecting a well-groomed insider with the standard pedigree from the business and marketing sides of the operation

Poussot Tapped As Wyeth CEO – Inherits Full Pipeline, Takeover Concerns

With the appointment of 20-year veteran Bernard Poussot as CEO, Wyeth is following a traditional approach to chief exec succession -avoiding drama by selecting a well-groomed insider with the standard pedigree from the business and marketing sides of the operation

Back in line

AHP CEO-designate Robert Essner is named Treasurer of the Pharmaceutical Research & Manufacturers of America March 31, putting him in line behind Chairman-elect Fred Hassan (Pharmacia) to head the association. Essner previously reported to Hassan when they were execs at Wyeth and Sandoz. Hassan issued a statement congratulating Essner on his appointment as CEO of AHP in March (1"The Pink Sheet" March 12, p. 18)

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037454

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel